BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Bromocriptine Impurities | Bromocriptine Impurities serve as essential components in comprehensive pharmaceutical quality assessment, underpinning the efficacy of drugs targeting Parkinson's disease, hyperprolactinemia, and acromegaly. By elucidating stability and degradation pathways, they ensure unparalleled therapeutic reliability and safety, preserving the sanctity of pharmacological standards and enhancing medical treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Bromocriptine Mesylate | Bromocriptine mesylate is the mesylate salt of Bromocriptine. It is a dopamine receptor agonist. It is a derivative of the ergotoxin group of ergot alkaloids. Uses: Antiparkinson agents. Group: Pharmaceutical. CAS No. 22260-51-1. Pack Sizes: 500 mg. Product ID: B2693-463773. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromodeoxyuridine (BrdU) | 5-Bromo-2'-deoxyuridine (5-BrdU) is a thymidine analog that can be incorporated into newly synthesized DNA to label it. Group: Pharmaceutical. CAS No. 59-14-3. Pack Sizes: 5 g. Product ID: B2706-004257. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromoethylamine Impurities | Bromoethylamine Impurities are crucial in the biomedical field for evaluating the purity and safety of pharmaceutical compounds. These impurities are meticulously analyzed to ensure the efficacy and minimal side effects of drugs used to treat neurological disorders, such as epileptic seizures, and depressive episodes, offering an invaluable resource for quality control in drug development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromopride Impurities | Bromopride Impurities are crucial in the pharmaceutical industry for ensuring drug purity and safety, particularly for medications targeting gastrointestinal disorders. These impurities are studied to assess the pharmacokinetics and pharmacodynamics of bromopride, enhancing the therapeutic efficacy and minimizing adverse effects in treating nausea and vomiting. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brompheniramine Impurities | Brompheniramine Impurities play a crucial role in the biomedical industry, primarily utilized in the analysis and quality control of brompheniramine, an antihistamine used to manage allergic conditions. Monitoring these impurities ensures the safety and efficacy of drugs used for allergies and cold-related symptoms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromuron-[d6] | Bromuron-[d6] is a deuterium labelled Bromuron, a urea herbicide. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-014109. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bronopol Impurities | Bronopol Impurities are crucial in the pharmaceutical field to ensure the safety and efficacy of bronopol-containing drugs. These impurities are thoroughly analyzed during drug formulation and stability testing, primarily in antimicrobial products used to treat eczema, acne, and other skin infections, guaranteeing minimal adverse effects and optimal therapeutic performance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bropirimine | Bropirimine is an immunostimulant as well as anticancer agent and has been found to exhibit direct antitumor activity. Group: Pharmaceutical. CAS No. 56741-95-8. Pack Sizes: 1 g. Product ID: B2692-334797. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Broussonin B | Broussonin B is a natural phenols found in the branch of Broussonetia papyrifera, it has moderate inhibitory activities against a chymotrypsin-like activity of the proteasome. Group: Pharmaceutical. CAS No. 73731-86-9. Pack Sizes: 1 mg. Product ID: NP5061. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Broussonin C | Broussonin C is a natural phenol found in the branch of Broussonetia papyrifera, it exerts simple reversible slow-binding inhibition against diphenolase. Group: Pharmaceutical. CAS No. 76045-49-3. Pack Sizes: 1 mg. Product ID: NP4657. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bruceine D | Bruceine D is extracted from the barks of Ailanthus altissima. It is an inhibitor of hepatocellular carcinoma growth and inhibits the growth of three pancreatic cancer cell lines, which acts by targeting β-catenin/jagged1 pathways. It also induces cytotoxicity in Capan-2 cells by inducing cellular apoptosis involving the mitochondrial pathway. It may be used as a lead compound for new viricides, or a natural viricide. Group: Pharmaceutical. CAS No. 21499-66-1. Pack Sizes: 10 mg. Product ID: NP1540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bruceine E | Bruceine E is extracted from the seeds of Brucea javanica (L.) Merr. It could reduce blood glucose concentration remarkably and may be used as an insulin secretagogue. Group: Pharmaceutical. CAS No. 21586-90-3. Pack Sizes: 1 mg. Product ID: NP1578. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Brusatol | Brusatol is a triterpenoid isolated from the Brucea javanica plant. Brusatol acts as an Nrf2 inhibitor with anticancer activity. Uses: Anti-tumor. Group: Pharmaceutical. CAS No. 14907-98-3. Pack Sizes: 100 mg. Product ID: B2703-464816. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bryonamide A | Bryonamide A is an alkaloid isolated from Bryonia aspera. Group: Pharmaceutical. CAS No. 75268-14-3. Pack Sizes: 1 mg. Product ID: NP0825. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bryonolic acid | Bryonolic acid isolated from the herbs of Sandoricum indicum. It induces a obviously increase in the expression of a phase 2 response enzyme and heme oxygenase 1 (HO-1) in a dose-dependent manner. Uses: Anti-allergic activity; anti-inflammatory and antioxidant activities. Group: Pharmaceutical. CAS No. 24480-45-3. Pack Sizes: 1 mg. Product ID: NP6506. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BS-181 HCl | BS-181 HCl is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9. Group: Pharmaceutical. CAS No. 1397219-81-6. Pack Sizes: 50 mg. Product ID: B0084-463412. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bucillamine | Bucillamine is an antirheumatic agent mainly used in Japan and Korea. Group: Pharmaceutical. CAS No. 65002-17-7. Pack Sizes: 1 g. Product ID: B1370-074453. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bucladesine Impurities | Bucladesine Impurities, crucial in pharmaceutical research, are used to identify potential effects and pharmacokinetic properties of bucladesine, a cyclic AMP analog. These impurities aid in refining formulations intended to treat cardiovascular conditions and certain neurological disorders, enhancing the understanding and therapeutic potential of the parent compound. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Buclizine hydrochloride | Buclizine hydrochloride is an antihistamine and anticholinergic of the piperazine derivative family. Group: Pharmaceutical. CAS No. 129-74-8. Pack Sizes: 1 g. Product ID: B0084-056872. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bufalin | Bufalin is a major digoxin-like immunoreactive component of the Chinese medicine Chan Su and has been shown to exert a potential for anticancer activity against various human cancer cell lines in vitro. Group: Pharmaceutical. CAS No. 465-21-4. Pack Sizes: 50 mg. Product ID: B0005-464396. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Buflomedil Impurities | Buflomedil Impurities are critical in biomedical research for ensuring the purity and safety of Buflomedil, a vasodilatory drug used in treating peripheral vascular diseases, especially occlusive arterial diseases. Studying these impurities aids in enhancing drug efficacy and developing more refined therapeutic agents for vascular ailments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bufuralol Impurities | Bufuralol Impurities are crucial in pharmaceutical research for studying metabolic pathways and biotransformation of bufuralol, a beta-blocker used for treating hypertension and arrhythmias. These impurities facilitate the understanding of potential side effects and drug interactions, thereby enhancing the overall safety and efficacy profile of beta-adrenergic antagonists. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bulleyaconitine A | Bulleyaconitine A is an alkaloid found in Aconitum bulleyanum. It has analgesic and anti-inflammatory properties and has been used for the treatment of chronic pain and rheumatoid arthritis. Uses: Bulleyaconitine a, an active indegrent from aconitum bulleyanum diel, has been found to be effective in the treatment of chronic pain and rheumatoid arthritis. Group: Pharmaceutical. CAS No. 107668-79-1. Pack Sizes: 50 mg. Product ID: B0005-465163. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bulleyanin | Bulleyanin is a natural diterpenoid found in the herbs of Rabdosia bulleyana, which can be solved in Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. Group: Pharmaceutical. CAS No. 123043-54-9. Pack Sizes: 1 mg. Product ID: NP1243. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bumetanide Impurities | Bumetanide Impurities, encompassing minor byproducts present during the synthesis of Bumetanide, are crucial in ensuring the purity and efficacy of the diuretic drug Bumetanide, which is primarily used to treat conditions like congestive heart failure, kidney disorders, and liver diseases by reducing fluid retention and lowering blood pressure. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Buparvaquone | Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. It is a promising compound for the therapy and prophylaxis of all forms of theileriosis. It has been shown to have antileishmanial activity in vitro. It can be used to treat bovine East Coast fever protozoa in vitro, along with the only other substance known - Peganum harmala. It is the only really efficient commercial therapy product in bovine theileriosis, where it has been used since the late 1980s. Group: Pharmaceutical. CAS No. 88426-33-9. Pack Sizes: 250 mg. Product ID: B2693-078913. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bupropion Impurities | Bupropion Impurities hold significant importance in pharmaceutical research, functioning as crucial elements in quality control to ensure Bupropion's safety and efficacy. By elucidating stability, formulation intricacies, and metabolic pathways, these impurities enhance therapeutic outcomes for major depressive disorder treatment and smoking cessation, providing a profound understanding of the drug's pharmacological attributes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Busperidone Impurities | Busperidone Impurities occupy an essential niche in pharmaceutical science, critically underpinning quality control and safety evaluations of the anxiolytic agent, busperidone. These impurities are meticulously examined to uphold the drug's efficacy and purity, thereby averting adverse outcomes and ensuring consistent therapeutic reliability in clinical use. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Buspirone Impurities | Buspirone Impurities, fundamental analytical benchmarks in the biomedical sector, are integral for the assurance of quality and reliability in buspirone synthesis. Their critical role encompasses evaluating buspirone's safety and efficacy, primarily utilized in anxiety disorder management, thus ensuring its purity and consistent therapeutic reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Busulfan Impurities | Busulfan Impurities, essential in pharmaceutical science, function as vital indices in assessing the purity and safety of Busulfan, a cornerstone in managing chronic myelogenous leukemia and preparatory transplant regimens. Their examination illuminates pharmacological intricacies and fortifies stringent quality control, upholding therapeutic effectiveness and safeguarding patient welfare. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butamirate Impurities | Butamirate Impurities, prevalent in pharmaceutical research, are key in assessing the purity, stability, and efficacy of cough suppressant formulations. Analyzing these impurities is crucial to ensuring the safety and effectiveness of butamirate-based medications, which are predominantly used to treat dry cough and related respiratory conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butamirate Impurity 1 | an impurity of Butamirate. Group: Pharmaceutical. CAS No. 92321-53-4. Pack Sizes: 20 mg. Product ID: B0491-467907. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butanol Impurities | Butanol Impurities, often encountered in pharmaceutical manufacturing, are scrutinized for their potential roles in drug contamination and efficacy assessment. These impurities can affect the stability and safety of medications, particularly in formulations treating neurological disorders and metabolic syndromes, underscoring the necessity for their precise identification and control in biopharmaceutical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butenafine-[13C,d3] HCl | Butenafine-[13C,d3] HCl is a labelled analogue of Butenafine HCl. Butenafine is a synthetic benzylamine antifungal. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: BLP-014875. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butenafine Impurities | Butenafine impurities, integral to the biomedical sector, play a vital role in quality assurance by safeguarding the effectiveness and safety of butenafine-derived antifungal therapies. Utilized against infections like athlete's foot, ringworm, and jock itch, impurity monitoring is essential for optimizing therapeutic efficacy and sustaining pharmaceutical standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butin | Butin is a natural flavonoid found in the seeds of Cassia tora. Butin has activity of antioxidant, which can protect cells against H2O2-induced apoptosis, oxidative DNA damage and oxidative mitochondrial dysfunction. Uses: Antioxidant. Group: Pharmaceutical. CAS No. 492-14-8. Pack Sizes: 10 mg. Product ID: NP2469. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butoconazole Impurities | Butoconazole Impurities are critical reference standards in the biomedical industry, primarily utilized in the quality control and development of antifungal formulations. These impurities ensure the efficacy and safety of butoconazole-based therapies, particularly used in the treatment of candidiasis. Analyzing these impurities aids in optimizing drug purity and therapeutic performance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butyl 2-fluoroprop-2-enoate | Butyl 2-fluoroprop-2-enoate. Group: Pharmaceutical. CAS No. 10011-39-9. Pack Sizes: 25 g. Product ID: B2699-192389. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butyldi-1-adamantylphosphine | Butyldi-1-adamantylphosphine (CAS# 321921-71-5 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 321921-71-5. Pack Sizes: 5 g. Product ID: B1370-002964. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butyl oleate | Butyl Oleate is used to fabricate nanoporous anatase TiO2 mesocrystals with tunable architectures and crystal phases. Group: Pharmaceutical. CAS No. 142-77-8. Pack Sizes: 2 kg. Product ID: B1370-356457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butylphthalide Impurities | Butylphthalide Impurities play a crucial role in the quality control and analytical development of butylphthalide-based pharmaceuticals. These impurities are monitored to ensure the purity and efficacy of drugs used primarily in the treatment of ischemic stroke and vascular dementia, offering insights into drug safety and therapeutic potential. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Butylphthalide (Natural) | Butylphthalide is an anti-cerebral-ischemia drug, which is first isolated from the seeds of celery, showed efficacy in animal models of stroke. It alleviates oxidative stress caused by chronic cerebral ischemia, improves cholinergic function, and inhibits amyloid beta accumulation, thereby improving cerebral neuronal injury and cognitive deficits. Uses: Antihypertensive;anti-cerebral-ischemia. Group: Pharmaceutical. CAS No. 6066-49-5. Pack Sizes: 50 mg. Product ID: B0005-464370. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BVT 2733 | BVT 2733 is a non-steroidal small molecule as a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor (IC = 96 ± 14 nM). Group: Pharmaceutical. CAS No. 376640-41-4. Pack Sizes: 25 mg. Product ID: B0084-474151. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BX-795 | 3-Phosphoinositide-dependent protein kinase 1 (PDK1) is a serine-threonine kinase that phosphorylates and activates a range of other kinases, including PKB, PKA, and certain isoforms of PKC. BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM, which is 140- and 1600-fold more selective than PKA and PKC. It is also a potent and relatively specific inhibitor of TBK1 with IC50 of 6 nM and IKK? with IC50 of 41 nM. Group: Pharmaceutical. CAS No. 702675-74-9. Pack Sizes: 25 mg. Product ID: B0084-194478. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Byakangelicin | Byakangelicin is an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. It is an inhibitor of aldose reductase used in the treatment of diabetic cataracts. Byakangelicin is a natural coumarin compound found in Murraya koenigii, Triphasia trifoliata, and other organisms. Group: Pharmaceutical. CAS No. 482-25-7. Pack Sizes: 10 mg. Product ID: NP1139. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Byakangelicol | Byakangelicol is a furanocoumarin derivative which shows inhibitory effects against P-glycoprotein at the blood-brain barrier. It acts as an anti-proliferative agent causing G2/M arrest in melanoma cells. Group: Pharmaceutical. CAS No. 26091-79-2. Pack Sizes: 10 mg. Product ID: B2703-465418. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| BzATP triethylammonium salt | The P2X purinergic receptors are ligand-gated ion channels that are activated by extracellular ATP. BzATP triethylammonium salt is a prototypic P2X7 receptor agonist that exhibits 5-10 fold greater potency than ATP with EC50 of 0.7 μM. It also exhibits partial agonist activity at P2X1 and P2Y1 receptors. BzATP can also be used as a photoaffinity probe to study adenine nucleotide binding to ATPases. Group: Pharmaceutical. CAS No. 112898-15-4. Pack Sizes: 25 mg. Product ID: B2693-359261. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C12-200 | C12-200 is almost a macromolecule. It contains multiple tertiary amines, the pKa of which should also be close to but no greater than 7. Ionizable lipids in combination with other lipids make up the lipid nanoparticles which are used to deliver RNA-based therapeutics. Group: Pharmaceutical. CAS No. 1220890-25-4. Pack Sizes: 1 g. Product ID: B1370-358162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C16 Ceramide | C16 ceramide is an endogenous ceramide, generated by ceramide synthase 6 (CerS6), that acts as a lipid second messenger to regulate apoptosis and stress signaling. It has also been found to activate NF-κB and PKCζ3. Uses: A predominant, rather hydrophobic natural ceramide. activates a cytosolic serine/threonine protein phosphatase in t9 cells; induces egf receptor phosphorylation in a-431 cells; stimulates ceramide-activated protein kinase. Group: Pharmaceutical. CAS No. 24696-26-2. Pack Sizes: 100 mg. Product ID: B1370-059982. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C18 ceramide | It is an endogenous bioactive sphingolipid. Uses: The sphingolipid ceramide. Group: Pharmaceutical. CAS No. 2304-81-6. Pack Sizes: 50 mg. Product ID: B1370-058857. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C29 | C29 is a potential TLR2 inhibitor. C29 inhibited TLR2/1 and TLR2/6 signaling induced by synthetic and bacterial TLR2 agonists in human HEK-TLR2 and THP-1 cells, but only TLR2/1 signaling in murine macrophages. Group: Pharmaceutical. CAS No. 363600-92-4. Pack Sizes: 100 mg. Product ID: B1370-007320. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C34 | C34 is a TLR4 inhibitor. Group: Pharmaceutical. CAS No. 40592-88-9. Pack Sizes: 100 mg. Product ID: B2693-473904. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C3-Spacer-CEP | C3-Spacer-CEP is used to insert a spacer arm in an oligonucleotide and may be added in multiple additions when a longer spacer is required. Group: Pharmaceutical. CAS No. 110894-23-0. Pack Sizes: 1 g. Product ID: B2706-331216. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| C646 | C646 is an inhibitor for histone acetyltransferase, and inhibits p300 with a Ki of 400 nM. Preferentially selective for p300 versus other acetyltransferases. Group: Pharmaceutical. CAS No. 328968-36-1. Pack Sizes: 25 mg. Product ID: B0084-370250. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| CA-4948 | CA-4948 is a potent and selective IRAK4 inhibitor that can be used for the treatment of cancers with dysregulated TLR/MYD88/IRAK4 signaling. Group: Pharmaceutical. CAS No. 1801343-74-7. Pack Sizes: 100 mg. Product ID: B0084-054015. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabazitaxel | Cabazitaxel increases CYP3A enzyme activities in rat hepatocytes. The mean ex-vivo human plasma protein binding of Cabazitaxel is 91.6%. Group: Pharmaceutical. CAS No. 183133-96-2. Pack Sizes: 500 mg. Product ID: B0084-461977. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabazitaxel Impurities | Cabazitaxel Impurities occupy a critical role in biomedical sectors, tasked with evaluating the purity and therapeutic efficacy of cabazitaxel, an antineoplastic agent targeting metastatic castration-resistant prostate cancer. Through meticulous identification and quantification, these impurities facilitate the safeguarding of the drug's safety and effectiveness in clinical treatments. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabazitaxel intermediate | Cabazitaxel intermediate is extracted from the barks of Taxus yunnanensis. Group: Pharmaceutical. CAS No. 1354900-65-4. Pack Sizes: 1 mg. Product ID: NP1479. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabergoline Impurities | Cabergoline impurities are critical in the biomedical industry as they assist in developing purification protocols for cabergoline, a drug used to treat Parkinson's disease and hyperprolactinemia. By understanding these impurities, researchers can enhance drug safety, efficacy, and stability, ultimately improving therapeutic outcomes for patients. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabergoline Impurity A | 6-Allyl-8β-carboxyergoline is a metabolite of cabergoline which is a dopamine D2-receptor agonist. Group: Pharmaceutical. CAS No. 81409-74-7. Pack Sizes: 5 mg. Product ID: B0497-467954. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabergoline Impurity B | European Pharmacopoeia (EP) Impurity B of Cabergoline. Group: Pharmaceutical. CAS No. 166533-36-4. Pack Sizes: 5 mg. Product ID: B0497-467955. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabergoline Impurity C | European Pharmacopoeia (EP) Impurity C of Cabergoline. Group: Pharmaceutical. CAS No. 126554-50-5. Pack Sizes: 5 mg. Product ID: B0497-467956. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabergoline Impurity D | A metabolite of Cabergoline, having affinity for D1 and D2 dopamine receptors in rat striatum. Group: Pharmaceutical. CAS No. 85329-86-8. Pack Sizes: 5 mg. Product ID: B0497-467953. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabotegravir (GSK744, GSK1265744) | Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, and inhibits the HIV-1 integrase catalyzed strand transfer reaction with IC50 of 3.0 nM. Phase 2. Uses: Hiv integrase inhibitors. Group: Pharmaceutical. CAS No. 1051375-10-0. Pack Sizes: 25 mg. Product ID: B0084-463362. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Caboxine A | Caboxine A is isolated from the herbs of Catharanthus roseus. Group: Pharmaceutical. CAS No. 53851-13-1. Pack Sizes: 1 mg. Product ID: NP0365. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabozantinib | Cabozantinib is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively. Group: Pharmaceutical. CAS No. 849217-68-1. Pack Sizes: 500 mg. Product ID: NP3655. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabozantinib Impurities | Cabozantinib Impurities are studied in the pharmaceutical industry for their roles in understanding the safety and efficacy of cabozantinib, a kinase inhibitor used in treating cancers like renal cell carcinoma and medullary thyroid carcinoma. Research on impurities is crucial for developing safer cancer therapeutics and ensuring drug purity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cabozantinib S-malate | Cabozantinib malate is the malate of Cabozantinib, a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively. Group: Pharmaceutical. CAS No. 1140909-48-3. Pack Sizes: 1 g. Product ID: B2693-457054. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cadalin Impurities | Cadalin Impurities serve as crucial reference materials in the pharmaceutical industry, primarily employed in characterizing the purity and stability of Cadalin-containing formulations. By identifying and quantifying these impurities, researchers aim to enhance the safety and efficacy of drugs designed to treat inflammation and various cancers. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.